Старение. Профессиональный врачебный подход

   4. Ames B. N., Shigenaga M.K., Hogen Т.М. Oxidants, antioxidants, and the degenerative diseasesof aging//Proc. Natl. Acad. Sci. USA. 1993. Vol. 90. P. 7915–7921.

  5. Andrews G.R., Sidorenko A., Andrianova L.F., Anisimov V. N. et al. The United Nation research agenda on ageing for the 21st cenmry // Успехи геронтологии 2001. Т. 7. С. 7–25.

   6. Anestiadis B.C.H, Tsiple T. T. Pathomorphosis of atherosclerosis and aging. Advances in Gerontology. – 2007. – Vol.20,№ 3. – P. 82.

   7. Anisimov S.V., Boheler К. R. Aging-associated changes in cardiac gene expression: Jarge scale transcriptome analysis // Успехи геронтологии 2003. Т. 11. С. 67–75.

   8. Anisimov V.N., Alimova I.N., Baturin D.A. et al. Dose-dependent effect of melatonin on life span and speontaneous tumor incidence in female SHR mice // Exp. Gerontol. 2003. Vol. 38. P. 449–461.

   9. Anno О., Kimmel M., Webb С.F. Mathematical modeling of the loss of te-lomereseqences//J.Theor. Biol.1995. Vol. J77. P. 45–57.

   10. Aragona M., Maisano R., Panetta S. et at. Telomere length maintenan ce in aging and carcinogenesis //Int. J. Oncol. 2000. Vol. 17. P. 981–989.

   11. Aronow W.S. Prevalence of CAD, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function //Am J Card, 2000; 86:1142–1143

   12. Artandi S., Chang S., Lee L. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice // Nature, 2000. Vol. 40. P. 641–645.

   13. Baker G.Т., Sprott R.L. Biornarkers of aging // Exp. Cerontol. 1988. Vol. 23. P. 223–239.

   14. Balmain A., GrayJ., Ponder B. The genetcs and genomics of cancer // Nature Genet. 2003. Vol. 33. P. 238–244.

   15. Bartke A., Brown-Borg H., Mattison J. et al. Prolonged longevity of hypopitui-tary mice// Exp. Gerontol. 2001. Vol. 36. P. 21–28.

   16. Bartsch C., Bartsch H., BUtsk D. E. et al (eds). The Pineal Gland and Cancer. Neuroimmunoendocrine Mechanisms in Malignancy. Berlin: Springer, 2001. 578 p.

   17. Bashkireva A.S., Artamonova V.G. Premature ageing diagnosis and prevention in occupational and environmental health//Adv. Gerontol. 2000. Vol. 5. P. 17–18.

   18. Bastiaanse E.M., Atsma D.E., Kuijpers M.M. Simvastatin-sodium delays cell death of anoxic cardiomyocytes by inhibition of the Na+/Ca2+ exchanger // FEBS Lett 1994;343(2):151–4.

   19. Beller J. Multimorbidity as a dilemma.Dtsch Arztebl Int. 2011 Jul;108(28–29):492

   20. Berstein L.M. Macrosomy, obesity and canсеr. New York: Nova Science. Publ. 1997.195 р.

   21. Bismark H.D. Obesity as pacemaking and common factor in polymorbidity in old age.

   22. Bjelakovic G. et al. «Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases» C ochrane Database of Systematic Reviews 2008, Issue 2.

   23. Blasco M.A. Telomerase beyond telomeres // Nature Rev. Cancer. 2002. Vol. 2. P. 1–7.

   24. Bodnar A. G, Ouellette M., Froikis M. et al. Extension of life span by introduction of telomerase into normal human cells//Sciences. J998. Vol. 279. P. 349–352.

   25. Boveri T. H. ZurFtagederEntstehung malingner Tumoren. Jena: Fischer. 1914.

   26. Boyd J.H., Burke J.D. Exclusion criteria of DSM-III: a study of co-occurrence of hierarchy-free syndromes //Arch Gen Psychiatry, 1984; 41: 983-9

   27. Brainard G. C, Kaver R., Kheifets L. T. The relationship between electromagnetic field and light exposure to melatonin and breast cancer risk: a review of the relevant literature Hi. Pineal Res. 1999. Vol. 26. P. 65–100.

   28. Brown W.T. Genetic diseases of premature aging as tnodels of senescence // Annu. Rev. Gerontol. Geriatr . 1990. Vol. 10. P. 23–42.

   29. Bruce S.G., Riediger N.D., Zacharias J.M., Young T.K. Obesity and obesity-related comorbidities in a Canadian First Nation population // Prev Chronic Dis, 2011

   30. Brvwn-Borg H. M., Rakoczy S.G. Catalase expression in delayed and premature aging mouse models // Exp. Gerontol. 2000. Vol. 35. P. 199–212.

   31. Btuher M., Kahn В.В., Kahn С.R. Extended longevity in mice lacking the insulin receptor in adipose tissue // Science. 2003. Vol. 299. P: 572–574.

   32. Burkhardt H., Wehling M. Difficulties in pharmacotherapy of the elderly. Urologe A. 2011 Mar;50(3):351-62

   33. Butchart E.G., Bodnar E. Trombosis, embolism and bliding // London. ICR Pablisher. 1992; 123–172.

   34. Butkr R.N., Fossel M., Harmon M. et al. Is there an antiaging medicine? // J. Gerontol. Biol. Science. 2002. Vol. 57A. P. B333–B338.

   35. Butler R . N., AustadS. N., Barztlai N. et al. Longevity genes: from primitive organisms to humans //J. Gerontol. Biol. Sci. 2003. Vol. 58A. P. 581–584.

   36. Campisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes // Exp. Gerontol. 2003. Vol. 38. P. 5–11.

   37. Carey E.C., Walter L.C., Lindquist K., Covinsky K.E. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders // J Gen Intern Med, 2004; Oct; 19(10): 1027-33